article · Scientific Reports
The necessity for reliable healthcare monitoring following the COVID-19 pandemic has highlighted the limitations of RF-based devices in medical settings. Visible light communication (VLC), which provides inherent security and is resistant to RF interference, is a good alternative. This work proposes a VLC system using DC-biased optical (DCO) orthogonal frequency division multiplexing (OFDM) for resilient, high-speed biomedical data transmission through indoor optical fading channel. In this system, data is modulated using quadrature amplitude modulation (QAM) with order 4 and 16. Four equalization methods; block-type, comb-type, superimposed training (ST), and blind channel estimation (CE); are implemented across three patient positioning scenarios. We integrate blind channel estimation and SLM-based PAPR reduction for a dynamic healthcare LiFi scenario. A comprehensive comparative analysis of CE techniques is conducted under realistic patient positioning (LOS/NLOS) conditions. An analysis of the trade-off between spectral efficiency and energy-to-noise ratio is examined in this context. Simulation results reveal a high Peak-to-Average Power Ratio (PAPR), reaching 15 dB with block-type CE. To mitigate this, Selected Mapping (SLM) is applied with three complex phase sequences, and three real sequences, achieving up to 4 dB PAPR reduction with no Bit Error Rate (BER) degradation. At 28 dB SNR, BER values were [Formula: see text], [Formula: see text], [Formula: see text], and [Formula: see text] for blind, block-type, comb-type, and ST CE, respectively. Spectral efficiency declines with increased multipath, yet blind CE maintains the highest performance, reaching 0.9 bits/s/Hz with 20 multipath components. Additionally, complex phase vectors in SLM provide an extra 1 dB PAPR gain over real-valued versions.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1038/s41598-026-43583-9
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.